Effect of the TEGO Connector in Preventing Tunneled Cuffed Hemodialysis Catheters From Dysfunction and/or Bacteremia

• Status: Completed
• Trial end date: 2011-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the trial was to assess whether use of the TEGO connector was able to reduce the incidence of a composite endpoint of TCC-related dysfunction (TCC-D)or TCC-related bacteremia (TCC-B) in chronic hemodialysis (HD) patients carrying the TEGO® connector vs controls receiving trisodium citrate 46.7%.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Erasme University Hospital
• Treatments: Citric Acid; Sodium Citrate

Criteria

Inclusion Criteria:

• Adult HD patients, prevalent or incident,carrying a tunneled cuffed catheter

• Tunneled cuffed catheter providing a mean blood flow superior to 250 ml/min

• Patients having signed an informed consent

Exclusion Criteria:

• Mature arterio-venous fistula

• Episode of TCC-related bacteremia 1 week before randomization